Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.
暂无分享,去创建一个
O. Simonetti | T. Parrish | R. Kim | D. Fieno | K. Harris | E. Chen | J. Bundy | J. Finn | F. Klocke | R. Judd | Kathleen E. Harris | Orlando Simonetti | Orlando P. Simonetti | Enn‐ling Chen | Enn‐ling Chen
[1] R. Jennings,et al. Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation. , 1974, The American journal of pathology.
[2] R. Jennings,et al. The Changing Anatomic Reference Base of Evolving Myocardial Infarction: Underestimation of Myocardial Collateral Blood Flow and Overestimation of Experimental Anatomic Infarct Size Due to Tissue Edema, Hemorrhage and Acute Inflammation , 1979, Circulation.
[3] F. Buonanno,et al. Quantification of Experimental Myocardial Infarction Using Nuclear Magnetic Resonance Imaging and Paramagnetic Ion Contrast Enhancement in ExcisedCanine Hearts , 1982, Circulation.
[4] R. Jennings,et al. Comparison of the effect of ischaemia and anoxia on the sarcolemma of the dog heart. , 1983, European heart journal.
[5] H. Weinmann,et al. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.
[6] R. Ehman,et al. Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. , 1984, Radiology.
[7] R. Jennings,et al. Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Effects of osmotic cell swelling on plasma membrane integrity. , 1985, Circulation research.
[8] R. Jennings,et al. Effect of Reperfusion Late in the Phase of Reversible Ischemic Injury: Changes in Cell Volume, Electrolytes, Metabolites, and infrastructure , 1985, Circulation research.
[9] D Revel,et al. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. , 1986, Radiology.
[10] R W Parkey,et al. Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration. , 1986, The American journal of cardiology.
[11] F. C. Dougherty,et al. Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium‐DTPA , 1986, Clinical cardiology.
[12] R. Peshock,et al. Magnetic resonance imaging of acute myocardial infarction: gadolinium diethylenetriamine pentaacetic acid as a marker of reperfusion. , 1986, Circulation.
[13] R. Peshock,et al. Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. , 1988, Journal of the American College of Cardiology.
[14] T Nakatani,et al. Determination of infarct size of acute myocardial infarction in dogs by magnetic resonance imaging and gadolinium-DTPA: comparison with indium-111 antimyosin imaging. , 1987, American journal of physiologic imaging.
[15] N. Yamada,et al. Serial assessment of myocardial infarction by using gated MR imaging and Gd-DTPA. , 1989, AJR. American journal of roentgenology.
[16] P. V. van Dijkman,et al. Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA--enhanced MR imaging. , 1989, Radiology.
[17] P. V. van Dijkman,et al. Diagnostic significance of gadolinium-DTPA (diethylenetriamine penta-acetic acid) enhanced magnetic resonance imaging in thrombolytic treatment for acute myocardial infarction: its potential in assessing reperfusion. , 1990, British heart journal.
[18] R. Edelman,et al. First-pass cardiac perfusion: evaluation with ultrafast MR imaging. , 1990, Radiology.
[19] M. Sprenger,et al. Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis. , 1990, The American journal of cardiology.
[20] C B Higgins,et al. Occlusive and reperfused myocardial infarcts: MR imaging differentiation with nonionic Gd-DTPA-BMA. , 1991, Radiology.
[21] P. V. van Dijkman,et al. Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. , 1991, Radiology.
[22] C B Higgins,et al. Reperfusion and irreversible myocardial injury: identification with a nonionic MR imaging contrast medium. , 1992, Radiology.
[23] K. Uğurbil,et al. Contrast‐enhanced first pass myocardial perfusion imaging: Correlation between myocardial blood flow in dogs at rest and during hyperemia , 1993, Magnetic resonance in medicine.
[24] B. Gersh,et al. Thrombolysis and Myocardial Salvage Results of Clinical Trials and the Animal Paradigm‐ Paradoxic or Predictable? , 1993, Circulation.
[25] Aeilko H. Zwinderman,et al. Magnetic Resonance Imaging During Dobutamine Stress for Detection and Localization of Coronary Artery Disease: Quantitative Wall Motion Analysis Using a Modification of the Centerline Method , 1994, Circulation.
[26] U. Sechtem,et al. [Magnetic resonance tomography imaging techniques for diagnosing myocardial vitality]. , 1994, Herz.
[27] F. Fedele,et al. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: role of magnetic resonance imaging. , 1994, American heart journal.
[28] R. Judd,et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. , 1995, Circulation.
[29] E. Atalar,et al. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. , 1995, Circulation.
[30] R. Kim,et al. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. , 1996, Circulation.
[31] Katherine C. Wu,et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. , 1998, Circulation.
[32] R O Bonow,et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. , 1998, Circulation.